According to the National Medical Products Administration, 76 innovative drugs were approved for market release in China in 2025, significantly exceeding the 48 approved in all of 2024 and setting a new record high. In addition, the total value of licensing transactions for innovative drugs in China exceeded $130 billion in 2025, with the number of transactions surpassing 150—also a record high. (CCTV News)